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Abstract
Thermodynamic modeling of Ebola viral RNA predicts the formation of RNA stem-loop structures at the 3 and 5 termini and panhandle
structures between the termini of the genomic (or antigenomic) RNAs. Sequence analysis showed a high degree of identity among Ebola
Zaire, Sudan, Reston, and Cote d’Ivoire subtype viruses in their 3 and 5 termini (18 nucleotides in length) and within a second region
(internal by approximately 20 nucleotides). While base pairing of the two conserved regions could lead to the formation of the base of the
putative stem-loop or panhandle structures, the intervening sequence variation altered the predictions for the rest of the structures. Using
an in vivo minigenome replication system, we engineered mutations designed to disrupt potential base pairing in the viral RNA termini.
Analysis of these variants by screening for enhanced green fluorescent protein reporter expression and by quantitation of minigenomic RNA
levels demonstrated that the upper portions of the putative panhandle and 3 genomic structures can be destabilized without affecting virus
replication.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction.
Ebola virus is a nonsegmented, negative-strand RNA
virus within the family Filoviridae. The following four
subtypes of the virus are currently recognized: Zaire, Sudan,
Cote d’Ivoire, and Reston. As a negative-strand virus, Ebola
virus is replication-competent only when its viral RNA is
tightly encapsidated by viral proteins. Thermodynamic
modeling of the Ebola virus genomic and antigenomic
RNAs suggests that RNA secondary structures could form
at the termini. Possible structures include individual stem-
loops at each of the viral genomic and antigenomic RNA
termini (Sanchez et al., 1989; Volchkov et al., 1999) as well
as panhandle structures that could form through base pairing
between the ends of a single strand of either the genomic or
the antigenomic RNAs (Volchkov et al., 1999). As the
noncoding regions at the 3 and 5 ends of the viral RNA are
the only elements of the RNA template necessary for rep-
lication (Muhlberger et al., 1998) and RNA–protein inter-
actions can often be mediated through RNA secondary
structures, it follows that the ribonucleoprotein complexes
involved in replication might involve one of these RNA
secondary structures. To investigate this possibility, we an-
alyzed the ability of each of the different Ebola subtype
viruses to form similar putative terminal RNA secondary
structures. Subsequently, we used site-directed mutagenesis
on an Ebola virus in vivo replicating minigenome system to
probe further the involvement of possible secondary struc-
tures in virus replication. The combination of these two
lines of study suggests that the upper portions of neither the
putative panhandle nor the putative 3 genomic stem-loop
structures are essential to the replication and life cycle of
Ebola virus.
Results and discussion
To determine the role of terminal RNA secondary struc-
tures in the life cycle of Ebola virus, the following two
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approaches were employed: sequence comparison and in
vivo analysis of Ebola virus minireplicons. Both sets of
experiments suggest that the upper portions of the putative
panhandle and 3 genomic structures can be destabilized
without affecting RNA replication.
Sequence analysis and thermodynamic modeling
The suggestion that predicted RNA secondary structures
play an important role in the life cycle of the virus would be
supported by the finding that the sequences of each of the
different viral subtypes has the potential to form similar
secondary structures. The sequence of the entire genome is
published for both Ebola-Zaire and Ebola-Reston subtype
viruses (Ikegami et al., 2001; Sanchez et al., 1989; Volch-
kov et al., 1999). Previously proposed predictions for the
simple stem-loop structures at both the 3 and the 5 termini
of the genomic and antigenomic termini of the Ebola-Zaire
(Sanchez et al., 1989; Volchkov et al., 1999) were updated
using the most recent version of the mFold thermodynamic
modeling program of Zuker and colleagues, which is based
on nearest-neighbor thermodynamic rules and excludes
pseudoknots and base triples (Zulker et al., 1999) (Fig. 1B).
While various RNA structures can always be predicted, the
structures we discuss are those which are the most thermo-
dynamically stable. Likewise, the proposed structure for the
panhandle forming between the termini of an individual
strand of Ebola-Zaire genomic or the antigenomic RNAs
(Volchkov et al., 1999) was updated (Fig. 1B). For Ebola-
Sudan, the 3 viral terminal sequence was also known (Ki-
ley et al., 1986). The previously unknown sequence of the 5
genomic terminus of Ebola-Sudan was determined by using
5 rapid amplification of cDNA ends (RACE). The sequence
adjacent to the first 15 nucleotides of the 5 genomic ter-
minus of Ebola-Cote d’Ivoire was also determined by using
direct RT-PCR.
Comparison of the terminal RNA sequences of the Ebola
Zaire, Sudan, Reston, and Cote d’Ivoire subtype viruses
showed a high degree of sequence identity for the 3 and 5
terminal 13–17 nucleotides (Fig. 1A). Each subtype virus
also exhibits a second region of highly conserved sequence,
approximately 34 to 40 nucleotides from either terminus.
Thermodynamic modeling predicts that the terminal se-
quences of each subtype virus could fold into relatively
simple stem-loop structures (Fig. 1B), as was predicted for
Ebola-Zaire, with the two regions of highly conserved se-
quence forming the base stem of the structures. The se-
quence above this initial conserved stem of 10–12 nucleo-
tides varies considerably among the different viral subtypes,
particularly at the 5 genomic termini. These differences
result in the prediction of different structures, with varia-
tions in internal stem lengths and loop sizes for each of the
viral subtypes. As with Ebola-Zaire, thermodynamic mod-
eling of the sequences of two other viral subtypes, Ebola-
Sudan and Ebola-Reston, predicts the ability of the 3 and 5
terminal sequences of their individual genomic or antigeno-
mic strands to base pair, forming a panhandle-like structure
(Fig. 1B). However, as was the case with the terminal
stem-loop structures, the sequence at the base of the pan-
handle structures is highly conserved, while the upper por-
tions of the putative panhandle are highly variable in both
sequence and predicted structure.
These results from the comparative sequence analysis
were somewhat ambiguous overall. While the potential for
base pairing to occur is conserved, there are no examples of
nucleotide sequence variation with concomitant mainte-
nance of base-pairing ability. Any such examples of co-
variation within the predicted base-paired regions would
have confirmed the necessity for that base pair in the life
cycle of Ebola virus. Without such examples, we can only
conclude that the actual sequences of the two highly con-
served regions of sequence at both the 3 and the 5 viral
termini are essential for the viral life cycle.
In vivo analysis of site-directed mutations in predicted
secondary structures
To gauge the importance of the potential RNA structures
in the life cycle of Ebola virus, we used an artificial Ebola-
Zaire virus in vivo replication system. In this system, the
replication of an Ebola-Zaire virus mini-antigenomic RNA
is supported by coinfection of transfected cells with Ebola-
Zaire standard support virus. The mini-antigenomic repli-
con [pEboGFP-XS()] consists of the open reading frame
for enhanced green fluorescent protein (eGFP) flanked by
469 nucleotides of the 5 terminal and 176 nucleotides of
the 3 terminal noncoding sequences (Fig. 2A). Human
embryonic kidney 293 cells were first infected with the
support virus and then immediately transfected with RNA
synthesized in vitro from the pEboGFP-XS() minireplicon
plasmid. After 48 h, monolayers were visually inspected for
eGFP expression (Fig. 2B). Green fluorescence was ob-
served only in cells transfected with pEboGFP-XS() and
infected with support virus. To establish further that the
minireplicons could be passed to uninfected 293 cells, the
supernatants of the transfected cells were incubated with
fresh monolayers of 293 cells and assayed for eGFP expres-
sion. After 48 h, extensive numbers of fluorescent cells were
observed (Fig. 2C), indicating that RNA derived from the
parent construct pEboGFP-XS() containing the wild-type
Ebola terminal sequences serves as an authentic substrate
for the replication machinery, and furthermore, that the
progeny RNAs can be packaged into discreet replicons
capable of entering new cells. The moderate increase in the
number of GFP-expressing cells (compare Fig. 2B and Fig.
2C) was consistently seen upon passage of the resulting
minireplicons from the primary transfection to uninfected
cells and represents further amplification of the minirepli-
cons.
The ability of variants containing engineered mutations
designed to disrupt the proposed base-pairing capability of
these terminal RNAs was evaluated in the above system first
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by screening for eGFP expression in transfected cells. Fur-
ther analysis involved both Western immunoblots of eGFP
expression and quantification of the levels of RNA replica-
tion and transcription, using quantitative real-time PCR.
Variations in transfection efficiencies were minimal, as is
evidenced by minimal deviations in data collected in mul-
tiple experiments. Control transfections always included the
standard mini-antigenomic construct transfected into non-
infected cells. Cells transfected with mini-antigenomic
RNA but not infected with Ebola virus never expressed
eGFP. Green fluorescence was also never seen for cells
infected with Ebola virus but not transfected with mini-
antigenomic RNA (data not shown). The ability of all con-
structs to replicate and to produce eGFP was monitored over
time. Select variants were passaged onto fresh 293 cells to
monitor for their ability to be packaged and passaged. There
Fig. 1. A high degree of nucleotide identity can be seen among the 3 and 5 termini of the RNA genomes of Ebola Zaire, Reston, and Sudan subtype viruses (A).
The genomic sequences at the RNA termini of the viruses of the different Ebola subtype viruses can be folded into thermodynamically stable secondary structures
(B) (Mathews et al., 1999; Zuker, Mathews, and Turner, 1999). The sequences for Ebola-Zaire and Ebola-Reston are known in their entirety (Elliot et al., 1993;
Ikegami et al., 2001; Sanchez et al., 1989; Volchkov et al., 1999). Terminal sequences for Ebola-Sudan (the 3 genomic terminal sequence was previously published
(Kiley et al., 1986)) and Ebola-Cote d’Ivoire were completed by a combination of RT-PCR and 5RACE. Sequence that was defined by a primer is italicized.
Nucleotides that vary in any of the subtype viruses relative to Ebola-Zaire are highlighted in bold color. Blue indicates nucleotides that differ in one other sequence;
red, in two other subtypes; green, in three other subtypes. Bold black is used for nucleotides that do not occur in all of the subtypes.
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were no substantial defects in packaging or passage of the
variants tested (data not shown).
As a negative-sense RNA virus, Ebola virus replication
is initiated at the 3 termini of the viral genome or anti-
genome. We thus began our studies by investigating any
potential role of a 3 genomic structure in the viral pro-
moter. The ability of individual nucleotides to play an
important role in viral replication, even once encapsidated
by nucleocapsid proteins, has been demonstrated with Sen-
dai virus (Vulliemoz and Roux, 2001), suggesting that it is
relevant to examine the role of the RNA sequence at the 3
genomic terminus in Ebola virus replication. Due to the
highly conserved nature of the base of the putative 3
genomic secondary structure, the first variants analyzed
contained only single point mutations in this predicted base-
paired region, starting at nucleotide 16 (potentially involved
in the uppermost, 12th, base pair of the stem) and working
downward in the putative stem to nucleotide 9 (potentially
Fig. 2. A representative experiment demonstrating the in vivo Ebola replication system in which 293 cells are first infected with Ebola standard support virus
and then transfected with in vitro transcribed minireplicon RNA. (A) Schematic diagram of parental Ebola minireplicon containing the eGFP open reading
frame. (B) 293 monolayers assayed 48 h posttransfection showing green fluorescent cells. (C) 293 monolayers assayed 48 h after incubation with supernatants
of primary transfections.
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involved in the 6th base pair of the stem) (Fig. 3A). Inter-
estingly, despite the sequence conservation in this region
between the subtypes of the virus, individual nucleotide
changes do not appear to affect significantly the replication
of Ebola virus, as determined by visual inspection for eGFP
expression from the mini-antigenomic construct, over time
(Fig. 3B). Similar results have been demonstrated with
respiratory syncytial virus, in which nucleotides that are
highly conserved at the 3 termini of the virus were rela-
tively unimportant for viral replication (Fearns, et al., 2002).
Our analysis also revealed that none of the base pairs pre-
dicted to occur in this region is individually essential to the
replication of Ebola virus. In fact, the only significant de-
crease in eGFP expression occurs with the G9A variant,
which still does produce eGFP at easily visible levels. While
we could not infer from these data whether the decrease in
eGFP expression for the G9A variant was due to the se-
quence change or the resulting change in structure, further
experiments suggested that the decrease resulted solely
from the sequence change (see below; Fig. 4A). It is likely
that the actual nucleotide sequence in close proximity to the
virus RNA terminus is part of a replication promoter, and
thus is more sensitive to base changes.
To investigate further the importance of the putative
stem-loop structure, we designed two sets of mutations that
destabilized the predicted 3 genomic structure more signif-
icantly than did knock outs of individual base pairs. The first
of these predicted stem structures (U13C, U16C, G35C)
was destabilized by 2.5 kcal/mol relative to the wild-type
structure (Fig. 4A). The second set of mutations resulted in
a structure predicted to be 4.7 kcal/mol less stable than the
wild-type structure, with such a large loop that the stem-
loop structure is unlikely to form (Fig. 4A). These variants
were designed to disrupt the putative 3 genomic structure
to assay for the requirement of an RNA structure during
replication, which initiates at the 3 end of the Ebola virus
RNAs. While they were designed to cause minimal effects
on the corresponding predicted 5 antigenomic structure,
which could be a nucleation site for protein binding, slight
changes for this 5 structure were nonetheless predicted.
The 5 antigenomic structure consists of two helices sepa-
rated by an internal loop, much like the 5 genomic structure
(Fig. 1B). The mutations introduced in these two variants
moved the location of the 5 antigenomic internal loop, but
did not lower the overall predicted thermodynamic stability
of the structure. Visual analysis of expression of eGFP from
either of these 3 genomic stem-loop variants confirmed
high levels of replication despite the mutations. These re-
sults were first confirmed by Western immunoblot analysis
and then by quantitation of the levels of mRNA in trans-
fected cells. These analyses revealed that the levels of eGFP
mRNA and expression varied by less than three-fold be-
tween each of the variants and the standard mini-anti-
genome from 22 to 48 h (data not shown). Quantitation of
Fig. 3. Mini-antigenomic variants that contain individual nucleotide changes at the 3 genomic viral terminus are not significantly affected in their ability to
produce eGFP. Although the comparison of the sequences of the different viral subtypes demonstrated an apparent sequence conservation at the 3 genomic
terminus, this mutagenesis analysis suggests that this effect is not due to an absolute replicative requirement for a particular nucleotide sequence. (A) Predicted
secondary structure for the 3 genomic terminus of Ebola-Zaire virus. Nucleotides that were changed during site-directed mutational analysis are shown in
bold. The three C residues at the 3 terminus are nonviral nucleotides added for optimal T7 promoter function and are not numbered. (B) The levels of eGFP
expression for variants containing changes in the nucleotides at the 3 genomic terminus of the minireplicon. For a description of the scale used, see Materials
and Methods, under RNA Transfections.
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the levels of negative-sense RNA present in the transfected
cells over time further verified that replication of the mini-
antigenomic constructs was not significantly affected by
disruption of the predicted 3 genomic stem-loop structure
(Fig. 4A). The lack of deviation between the RNA levels of
these variants and the RNA levels in the standard minirep-
licon (which passages, and thus is replicating, through mul-
tiple rounds) suggests that these variants are not defective in
any stage of the replication cycle.
On the basis of the apparent lack of involvement of a 3
genomic stem-loop RNA structure in the replication of
Ebola virus, we next engineered variants designed to test the
importance of the panhandle structure predicted to form
between RNA-strand termini. Published studies with nega-
tive-strand RNA viruses suggest that the importance of such
terminal complementarity is not uniform throughout the
order Mononegavirales. While panhandle formation ap-
pears to play a role in vesicular stomatitis virus (Wertz et
al., 1994; Whelan and Wertz, 1999), it does not appear to be
important to the replication of either Sendai virus (Tapparel
and Roux, 1996) or respiratory synctial virus (Fearns et al.,
2000). Nucleotides C19 and G1438 of Ebola-virus are pre-
dicted to form a base pair above the highly conserved stem
of the panhandle structure (Fig. 4B). As one of only two GC
base pairs in the central region of the putative panhandle, it
would play an essential role in the stability of any such
structure. We abolished the ability for this base pair to form
by mutating nucleotide G1438. Variant G1438C had no
significant decrease in replication, as indicated by expres-
sion of eGFP. Measurement of these eGFP levels by West-
ern immunoblot and quantitation of mRNA levels con-
firmed that eGFP mRNA and expression levels varied by
Fig. 4. Mini-antigenomic variants that are unable to form either a stable stem-loop structure at the 3 genomic termini (A) or a panhandle structure through
base-pairing of the two termini of an individual strand of genomic or antigenomic RNA (B) can replicate and produce eGFP at levels similar to the standard
mini-antigenomic construct. The three C residues at the 3 terminus are nonviral nucleotides added for optimal T7 promoter function and are not numbered.
RNA levels are representative and did not vary significantly in multiple experiments. For a description of the scale used to relate data from visual inspections
of eGFP production, see Materials and Methods, under RNA transfections. (A) Shown are the predicted secondary structures for two variants containing
multiple site-directed mutations at the 3 genomic termini, the levels of eGFP observed visually, and the levels of negative-sense RNA in cells transfected
with these variants. Despite the apparent conservation of potential to base pair at the 3 genomic terminus, this base pairing does not appear to play a
significant role in the replication of Ebola virus based on the replication of the mini-antigenomic construct. (B) The putative genomic panhandle structure
was significantly altered in the middle by mutating one of the nucleotides proposed to be involved in a single GC base pair. Free energy values were obtained
by including five C residues to form a connecting loop between the two base-paired termini. Replication of this altered mini-antigenomic construct was largely
unaffected by this change as measured by eGFP production and by the levels of replicating negative-sense RNA in the transfected cells. Thus, the predicted
genomic panhandle structure does not appear to be essential to the replication of Ebola virus.
215Rapid Communication / Virology 306 (2003) 210–218
less than three-fold between the variants and the standard
mini-antigenome from 22 to 48 h posttransfection (data not
shown). Quantitation of negative-sense RNA levels by real-
time PCR confirmed that there were also no significant
changes in the ability of these mini-antigenomic variants to
replicate (Fig. 4B). Taken together, these results indicate
that the upper portion of the putative panhandle structure is
not essential to the replication of Ebola virus.
In this study, we investigated the relevance of the base-
pairing ability of the terminal sequences of Ebola virus
RNA for viral replication. While the potential for individual
RNA stem-loop structures to form at the 5 and 3 viral
termini has been previously discussed (Sanchez et al., 1989;
Volchkov et al., 1999), the data presented here suggest that
the 3 genomic structure does not play an essential role in
the replication of Ebola virus as monitored through analysis
of a mini-antigenomic construct. Additionally, although a
role for base pairing between the first 14 complementary
nucleotides at each end was not ruled out through this study,
our analysis demonstrates that the previously predicted pan-
handle structure (Volchkov et al., 1999) is not required in its
entirety for viral replication.
Materials and methods
Cell lines and viruses
Human embryonic kidney 293 cells (ATCC CRL-1573)
were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum
(FBS). Vero E6 cells (ATCC CRL-1586) were cultured in
minimal essential medium (MEM) supplemented with 2%
FBS. Ebola-Zaire Mayinga 8U virus strain (Calain et al.,
1999; Sanchez et al., 1996) was used as the standard support
virus in all of the transfection experiments described. For
sequencing, RNA was extracted from high-concentration
stocks of Ebola-Sudan and Ebola-Cote d’Ivoire virus by
using TriPure Isolation Reagent (Roche) and the RNA ma-
trix from the Bio 101 RNAid kit (QBiogene). All experi-
ments involving Ebola virus were performed in a maximum
containment biosafety level 4 laboratory.
Sequencing of viral RNA termini
The sequence of the 5 genomic terminus of Ebola-
Sudan virus was determined by 5 rapid amplification of
cDNA ends (5 RACE), using a 5 RACE system (Invitro-
gen) as recommended by the manufacturer. The internal,
gene-specific primers used for the RT and PCR assays were
complementary to a region within the 5 genomic trailer of
Ebola-Sudan (RT primer: 5 att caa ggt ttc gaa gac ac 3;
PCR primer: 5 cat ata tta aat tca aat tta gaa gc 3). The
sequences of the 3 genomic RNA termini of Ebola-Sudan
and Ebola-Cote d’Ivoire viruses, internal to the ultimate 15
nucleotides, were determined by using the Access direct
RT-PCR kit (Promega; Sudan RT and 3 PCR primer: 5 ttt
aag act ttt tgt gtg cg 3; Sudan 5 PCR primer: 5 act agt taa
att gtc tcc 3; Cote d’Ivoire RT primer: 5 aga cat acc atg ttg
atg g 3; Cote d’Ivoire PCR primers: 5 tag caa aga gga gaa
tct caa tct c 3 and 5 ccc tgg aca cac aaa aaa g 3). The PCR
products were purified by using the QiaQuick PCR Purifi-
cation kit (Qiagen) and sequenced directly or after being
subcloned with the TOPO TA cloning kit (Invitrogen), by
using Big Dye Terminator Cycle Sequencing Ready Reac-
tion Mix (ABI) and an ABI Prism 377 DNA Sequencer.
Plasmids and RNA
Standard Ebola virus mini-antigenome (pEboGFP-XS();
J.S. Towner and S.T. Nichol, unpublished data) consists of
the open reading frame for enhanced green fluorescent pro-
tein (Clontech) surrounded by 469 nucleotides of the 5
terminal and 176 nucleotides of the 3 terminal noncoding
sequences of the antigenomic strand of the Mayinga strain
of Ebola-Zaire virus. Additionally, the 5 terminal se-
quences are preceded by three guanosine residues to ensure
maximum RNA synthesis from the T7 promoter, while the
extreme 3 terminus of the primary transcript encodes for
the hepatitis delta virus antigenome-derived ribozyme (Patt-
naik et al., 1992; Perrotta and Been, 1991), which catalyzes
a cleavage event to generate the correct 3 terminus for the
mini-antigenome. Standard Ebola virus minigenome, used
to normalize negative-strand-specific RNA quantification
reactions, contains the terminal sequences of the genomic
strand of Ebola-Zaire virus surrounding the open reading
frame for eGFP (pEboGFP(); J.S. Towner and S.T. Ni-
chol, unpublished data). Variants in the mini-antigenomic
construct were created by using PCR mutagenesis in which
amplification was primed with oligonucleotides containing
the desired mutation(s).
RNA was synthesized in vitro by using T7 RNA poly-
merase from plasmids that were first linearized with BstEII.
The transcription reactions, consisting of 50 nM linearized
plasmid DNA, 40 mM Tris–Cl pH 8.0, 15 mM MgCl2, 5
mM DTT, 1 mM spermidine, 1 mM each of ATP, GTP,
CTP, and UTP, and 1 unit/l of T7 RNA polymerase (New
England Biolabs), were incubated at 37°C for 2 h, after
which time the reactions were diluted two-fold into 1
RNase-free DNase buffer (Ambion), RNase-free DNase
(0.04 units/l; Ambion) was added, and incubation was
continued at 37°C for 2 h. The RNA was then extracted with
acidic phenol/chloroform (1:1; pH 5.2), precipitated with
ethanol, and resuspended in 45 l H2O prior to an additional
DNase treatment with the DNA-free kit (Ambion). The
RNA was further purified from unincorporated nucleotides
by using an RNeasy purification column (Qiagen). RNA
were determined by absorbance at 260 nm, using an exper-
imentally determined extinction coefficient of 1.3  107
(Dawson et al., 1986; Zaug et al., 1988).
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RNA transfections, protein extraction, and RNA
purification
293 cells were infected with Ebola virus at a multiplicity
of infection of 10 prior to transfection. In vitro transcribed
RNA (1 g/25 mm well) was transfected into these cells by
using DOTAP transfection reagent (Roche). Expression of
eGFP and replication of RNA were monitored in transfected
cells for up to 48 h. Data from visual inspection of the
production of eGFP in the cells were catalogued on a scale
of 1 to 4. In this scale, 4 represents the amount of green
cells seen in a transfection with standard mini-antigenomic
RNA; variants labeled 1 produced only one to three green
cells in the entire well; variants labeled 2 produced two to
four green cells per field of vision at 320 resolution, and
variants labeled 3 had significant, but not wild-type-like,
numbers of green cells. Proteins and RNA were separately
extracted from cells at various times posttransfection. Cul-
ture medium was removed and the wells were washed with
phosphate-buffered saline. For protein extracts, lysate made
after the addition of 200 l of lysis buffer [50 mM HEPES
pH 7.5, 0.1% SDS, 1x Complete protease inhibitor cocktail
(Roche)] to each well was frozen and -irradiated (2  106
rads) prior to use. RNA was isolated with the TriPure
Isolation Reagent (1 milliliter per well) and was purified by
using an RNaid kit (Bio 101) into 50 l H2O. mRNA was
purified from this total RNA by using the Oligotex mRNA
Isolation kit (Qiagen). The results from transfections were
confirmed in multiple experiments.
Western immunoblot analysis
Protein extracts from transfected cells were loaded on
12% Bis–Tris polyacrylamide gels and run in MOPS run-
ning buffer (Novagen). Gel contents were transferred to
polyvinylidene difluoride (PVDF) membranes by using a
semidry apparatus (Bio-Rad). Membranes were first probed
with mouse anti--actin (1:500 dilution; Sigma) and mouse
anti-GFP (1:2000 dilution; Sigma) antibodies and subse-
quently with horseradish peroxidase linked anti-mouse sec-
ondary antibody (1:5000; Roche). Antibodies were reacted
with the ECL Plus kit (Roche) and visualized by using a
PhosphorImager Storm (Amersham). Bands representing
actin and eGFP extracted from transfected cells were quan-
tified by using the ImageQuant Software (Amersham). The
amount of eGFP produced in cells as determined by West-
ern immunoblot was normalized relative to -actin.
RNA quantification
The amount of RNA purified from cells that were trans-
fected with different variants of mini-antigenome was com-
pared by using a real-time PCR-based fluorescent assay. For
this assay, either negative-sense eGFP RNA and GAPDH
mRNA or eGFP mRNA and GAPDH mRNA were first
converted to cDNA in a single RT reaction containing
primers specific for each of these RNAs (negative-sense
eGFP primer: 5 ctg ctg ccc gac aac ca 3; eGFP mRNA
primer: 5 acc atg tga tcg cgc ttc tc 3; GAPDH mRNA
primer: 5 act tga ttt tgg agg gat ctc gct cc 3). RNA (3.5 l
in a final reaction volume of 10 l) was incubated in 1x
M-MLV RT buffer (Promega), supplemented with each
NTP (0.5 mM), and the two DNA primers (1 M each) at
55°C for 3 min prior to the addition of M-MLV RT (2
units). Reactions were incubated at 55°C for 15 min and
then diluted five-fold with H2O prior to inactivation of the
RT by incubation at 95°C for 30 min. The primers used in
the RT reaction were specific for one of three RNAs: (1) the
positive-sense eGFP coding region (complementary to both
the Ebola mini-antigenome and the eGFP mRNA; 5 acc atg
tga tcg cgc ttc tc 3); (2) the negative-sense eGFP coding
region (complementary to the Ebola mini-genome; 5 ctg
ctg ccc gac aac ca 3); or (3) the housekeeping gene
GAPDH mRNA (5 gaa ggt gaa ggt cgg agt c 3 and 5 gaa
gat ggt gat ggg att tc 3).
For the PCR-based quantification assay, 1/25th of each
cDNA-containing reaction was mixed with two PCR prim-
ers (900 nM each) and one fluorogenic probe (200 nM; for
eGFP, 5 ccc agt ccg ccc tga gca aag a 3; for GAPDH, 5
caa gct tcc cgt tct cag cc 3) in 1x TaqMan Universal Master
Mix (Applied Biosystems) in a final volume of 25 l. The
probes employed in these reactions contained the reporter
dye FAM at its 5 terminus and either QSY7 (for the eGFP
specific probe) or TAMRA (for the GAPDH-specific probe)
at the 3 terminus. The primer concentrations used were
determined in control reactions to give the highest sensitiv-
ity and, therefore, reproducibility for these assays. For each
cDNA/primer combination used in the RT reactions, there
was a corresponding real-time PCR quantification reaction
that amplified the positive-sense eGFP cDNA, the negative-
sense eGFP cDNA, or the GAPDH cDNA. These reactions
were heated to 50°C for 2 min, followed by heating to 95°C
for 10 min to activate the AmpliTaq polymerase. They were
then subjected to 40 cycles of amplification by alternately
incubating at 95°C for 15 s and 60°C for 1 min. All PCR
assays were performed in triplicate. The amplification reac-
tions were performed in an ABI 7700 Sequence Detection
machine (Applied Biosystems).
The amount of each RNA present in the samples from
each transfection was determined on the basis of a standard
curve created with minigenome or mini-antigenome synthe-
sized in vitro. For each PCR series, the threshold cycle (CT)
value was set within the linear range of DNA amplification
for all the productive reactions. To compensate for any
differences in the total amounts of RNA included in the RT
reactions, all of the values obtained for the eGFP reactions
were first normalized to the relative amounts of GAPDH
mRNA in each sample and further normalized by subtract-
ing out any background seen in transfected but noninfected
cells. RNA transfected into these cells did not begin to
degrade significantly until roughly 20 h posttransfection.
While the real-time quantitative PCR assay was specific for
217Rapid Communication / Virology 306 (2003) 210–218
a given sense of eGFP RNA, some eGFP RNA of the
opposite sense was amplified in these reactions, yielding a
background level two to three orders of magnitude below
the actual amount of RNA in the reaction. Although this
nonspecific background was slight, it nonetheless masked
replication of the minigenome at early time points. Thus, all
values reported occur at later time points, subsequent to the
linear phase of replication of the mini-antigenome.
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